LH · Labcorp

S&P 500 #366 · NYSE

Risiko 3/10 · Healthcare diagnostics steady · $314.23 ▲ 4.34%

Kennzahlen

• Price $314.23
• Market cap $25.8B
• P/E (ttm) 27.83
• Div yield 0.96%
• 52-wk range $244.52 – $315.77
• Index rank #366 / —

Wichtigste Risiken

• Reimbursement rate cuts from CMS/payers (Revenue) — MED
• Biopharma client budget cuts affecting CRO unit (Revenue) — MED
• Drug development segment CRO competition (Market share) — LOW
• Integration risk from acquisitions (Margins) — LOW

Fazit

Labcorp combines the #2 U.S. clinical lab network with a major contract research organization (CRO) serving pharma drug development.

Interaktive Analyse öffnen → Teilen

Recherche, keine Anlageberatung.